Presentation and management of nervous system cavernous malformations in children: A systematic review and case

Uma V Mahajan1, Mohit Patel1, Jonathan Pace1

  • 1Department of Neurosurgery, University Hospitals Cleveland Medical Center, and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Brain Circulation
|October 21, 2022
PubMed

Insights

Cerebral cavernous malformations (CMs) in children often cause seizures. Surgical treatment is recommended for symptomatic, accessible CMs, yielding good outcomes and seizure control.

Area of Science:

  • Pediatric Neurology
  • Vascular Malformations
  • Neurosurgery

Background:

  • Cerebral cavernous malformations (CMs) affect up to 0.5% of children.
  • These vascular lesions pose risks of hemorrhage, seizures, and neurological deficits.

Purpose of the Study:

  • To review the literature on pediatric cerebral cavernous malformations.
  • To report a case of supratentorial CM in a pediatric patient.
  • To analyze treatment outcomes and inform therapeutic strategies.

Main Methods:

  • Literature search of five databases for articles published before 2020.
  • Inclusion of cohort and case series studies of children under 12 years.
  • Pooled analysis of data from 16 selected studies, totaling 558 children.

Main Results:

  • 46.1% of pediatric CM patients experienced seizures.
  • 88.4% of surgically treated patients achieved total resection.
  • 85.1% of epilepsy patients were seizure-free (Engel Class 1) post-surgery.
  • 3.4% developed new neurological deficits over 4.1 years follow-up.

Conclusions:

  • Surgical intervention is a recommended first-line therapy for symptomatic, surgically accessible pediatric CMs with seizures.
  • Further research is needed on the long-term outcomes of minimally invasive treatments like radiosurgery and laser ablation in pediatric populations.